Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation
about
Ultra-performance liquid chromatography mass spectrometry and sensitive bioassay methods for quantification of posaconazole plasma concentrations after oral dosing.Understanding variability in posaconazole exposure using an integrated population pharmacokinetic analysis.Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapyPosaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer.Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies.Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.Plasma concentrations of posaconazole administered via nasogastric tube in patients in a surgical intensive care unit.Therapeutic drug monitoring of posaconazole in allogeneic hematopoietic stem cell transplantation patients who develop gastrointestinal graft-versus-host disease.Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients.Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome.Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.Current concepts in antifungal pharmacology.Triazole antifungal agents in invasive fungal infections: a comparative review.Safety and interactions of new antifungals in stem cell transplant recipients.Posaconazole therapeutic drug monitoring in the real-life setting: a single-center experience and review of the literature.Treatment principles for the management of mold infections.Our 2015 approach to invasive pulmonary aspergillosis.Dosing of antifungal agents in obese people.Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation.Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome.Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections.Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections.Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient VariabilityRhizomucor and scedosporium infection post hematopoietic stem-cell transplant.Posaconazole concentrations after allogeneic hematopoietic stem cell transplantation.In vitro-in vivo extrapolations to evaluate the effect of concomitant drugs on tacrolimus (FK506) exposure.Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection.
P2860
Q34309527-67CB8038-378B-4856-8D67-2DDEBD8C3EA4Q34596750-D4B288AD-C7A9-44F3-BFBC-502C31842C0FQ34737174-C8C142D7-9AB7-43C5-9F8C-65AD08E60483Q35262607-2D45F945-8753-455F-BA27-8E58B4ED2FCEQ35859959-8DD06BA9-3EDC-4B9C-AA14-2069C5434BDEQ35959480-489D8073-8940-4068-88AE-CED32502F041Q36018743-4BE9E2EB-31ED-4E07-A5D5-B8020BDDA682Q36171717-6D3D65BE-23F3-4782-88A9-2E3ABC5775D5Q36276966-08CB93AF-6034-4EC2-B752-3CB9965C6C5BQ36396176-A32F4B54-F058-4244-A340-F6371751F727Q36396203-C6C781E5-9E93-4C7F-B0DD-5F45F0420520Q37203849-B4C96A3A-8E01-46BE-9E53-6B2187C2671AQ37813420-2E249D34-7F24-47A3-A47A-57E2254AAA4AQ37908856-01D6B3BF-8870-456B-92E5-C393CB0DF9E8Q37964703-D9C1E308-4470-4420-9C77-DF4A81D27ADEQ38036740-472C8B60-C39F-44A5-A953-2D7139BC8AC0Q38122347-2D554302-D3B6-4B03-9594-B40FB60590C3Q38265845-A73FBE0A-D6B4-4217-834C-B9E7854A6F5CQ38391049-5C7B1CDF-ED61-4540-8039-F42A4FECF132Q38660761-5EA61932-513A-4F46-AEAB-A027F2C2B4FBQ40140538-35FC4A89-BDB3-4DB8-B976-8B6BEECC93E0Q40298087-C6F919E0-6264-478E-ACCA-BDD6AA302904Q40517272-777E5BAB-1A14-4405-9B36-656423B0ECA4Q40841377-13144915-5128-47BC-ABEC-E422D77C1185Q41291872-F286B400-3029-4FC6-BF07-50897410B259Q41991703-1EA42C25-D74E-4A41-BFAE-AD95206E525FQ42726610-E9374101-F927-4834-A5DE-64EA3DA5016EQ44162406-1A15C620-0112-4DE1-B5E2-199DE501695CQ47760575-81BA8C0C-2B4F-4094-B2A5-FE2B13EF48EFQ52777337-00BD1872-D226-4C55-8433-99675A6424F1
P2860
Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Factors influencing pharmacoki ...... neic stem cell transplantation
@ast
Factors influencing pharmacoki ...... neic stem cell transplantation
@en
Factors influencing pharmacoki ...... eic stem cell transplantation.
@nl
type
label
Factors influencing pharmacoki ...... neic stem cell transplantation
@ast
Factors influencing pharmacoki ...... neic stem cell transplantation
@en
Factors influencing pharmacoki ...... eic stem cell transplantation.
@nl
prefLabel
Factors influencing pharmacoki ...... neic stem cell transplantation
@ast
Factors influencing pharmacoki ...... neic stem cell transplantation
@en
Factors influencing pharmacoki ...... eic stem cell transplantation.
@nl
P2093
P2860
P356
P1476
Factors influencing pharmacoki ...... neic stem cell transplantation
@en
P2093
J J Vehreschild
K Abduljalil
M J G T Rüping
P2860
P304
P356
10.1128/AAC.01027-09
P407
P577
2009-10-26T00:00:00Z